Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

NCT07003295 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

NIH

Sponsor class

Conditions

Recurrent Mantle Cell Lymphoma
Refractory Mantle Cell Lymphoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Glofitamab
BIOLOGICAL: Obinutuzumab
PROCEDURE: Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)